S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LXRX Lexicon Pharmaceuticals Inc

0.701101

-0.0047 (-0.67%)

Last Updated: 03:15:16

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Lexicon Pharmaceuticals Charts.

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Lexicon Pharmaceuticals Charts.

Lexicon Pharmaceuticals Inc News

Form 8-K - Current report
Wednesday 8 January 2025 (7 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Friday 3 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 3 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Lexicon Appoints Scott Coiante as Chief Financial Officer
Friday 3 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)
Saturday 21 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Tuesday 10 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
Wednesday 27 November 2024 (2 months ago) • GlobeNewswire Inc.

Lexicon Pharmaceuticals to Participate in December Investor Conferences
Tuesday 26 November 2024 (2 months ago) • GlobeNewswire Inc.

Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
Friday 22 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

More Lexicon Pharmaceuticals Inc News Articles

Australian SE All Ordina...

Commonwealth Bank Of Aus...

AUD vs US Dollar

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions